Announcement
16 Mar 2020
In March 2020, the USTR announced a set of exclusions from the additional tariffs on a number of medical products from China.
Source
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
Prolonged: 10 Nov 2026
United States of America: US Administration provides temporary exclusions on Section 301 tariffs from China (extended until January 2027)
Implemented: 30 Sep 2023
United States of America: USTR excludes medical products from China Section 301 Tariffs
End prolongation: 30 Nov 2021
United States of America: COVID-19 exclusions from China Section 301 Tariffs
End prolongation: 14 Jun 2024
United States of America: Retaliation against China for intellectual property practices
See all
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
15689
187